Clinical stage drug development company Syntara (ASX:SNT) is set to get a big boost in exposure within the blood cancer…
Fresh off reporting final interim data from their Phase 2 clinical trials for PXS-5505 to treat myelofibrosis, biotech company Pharmaxis…
The pharmaceutical industry is an incredibly competitive space with new drug discoveries cropping up all the time, giving hope that…